October 15, 2025 a 03:43 pm

COO: Fundamental Ratio Analysis - The Cooper Companies, Inc.

The Cooper Companies Inc. Stock Image

The Cooper Companies, Inc. operates in both the CooperVision and CooperSurgical segments. This diverse business model provides it with a wide market reach in vision correction and women's health care. With its innovative product offerings, the company continues to exhibit potential for growth in the medical devices sector.

Fundamental Rating

The current fundamental analysis of The Cooper Companies, Inc. shows a range of performance across different financial metrics. Here’s a breakdown of the ratings:

Category Score Visualization
Discounted Cash Flow (DCF) 4
Return on Equity (ROE) 3
Return on Assets (ROA) 5
Debt to Equity 1
Price to Earnings (P/E) 2
Price to Book (P/B) 4

Historical Rating

Comparing The Cooper Companies, Inc.'s current and past scores offers insight into its financial trajectory:

Date Overall Score DCF ROE ROA Debt to Equity P/E P/B
2025-10-14 3 4 3 5 1 2 4
Previous 0 4 3 5 1 2 4

Analyst Price Targets

Analyst estimates indicate a positive outlook with varied price target evaluations:

High Low Median Consensus
$100 $64 $85 $84.14
Stock Price Chart

Analyst Sentiment

The overall sentiment from analysts shows a tendency towards holding and buying:

Recommendation Count Visualization
Strong Buy 0
Buy 15
Hold 7
Sell 1
Strong Sell 0

Conclusion

The Cooper Companies, Inc. demonstrates strong potential in the healthcare sector with a robust product lineup in both vision and women's health segments. Despite the mix of fundamental scores, the company’s innovative stance and market reach merit a favorable outlook. Analyst sentiments align with a generally positive perception, underlined by a strong buy signal. However, the company's debt levels and valuation ratios need close monitoring to mitigate any financial risks. In conclusion, while there are challenges to address, the potential growth prospects remain noteworthy.